Ankylosing Spondylitis Trial, Recruiting NCT07633730 Sponsor: Marmara University Condition: Ankylosing Spondylitis
Back to Ankylosing Spondylitis

Ankylosing Spondylitis Trial, Recruiting

NCT07633730
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You have been diagnosed with a condition called ankylosing spondylitis (a type of inflammatory arthritis affecting the spine), confirmed using a standard set of medical criteria called the Modified New York Criteria
  • You are already receiving treatment that keeps your condition under control, but you still have ongoing back pain
  • You are willing to take part in the study

Who may not be able to join:

  • Your body weight relative to your height (BMI) is above 35 (confirm with trial site if unsure of your BMI)
  • You have had surgery on the middle part of your back (thoracic/chest area) in the past
  • You have an intellectual disability or significant learning difficulty
  • You have a major mental health condition
  • You were born with an abnormality or unusual structure in your spine
  • You are pregnant
  • You have a history of problems with bleeding or blood clotting
  • You currently have an active infection anywhere in your body or in a specific local area
  • You have a known allergy to any of the medications that would be injected as part of this trial
  • You have unstable blood pressure or circulation problems (confirm with trial site)
  • Your ankylosing spondylitis is currently in an active flare, meaning your inflammation levels are high or your joints are actively inflamed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fatma B Akdağ, Research Assistant, Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation

Phone: +90 537 452 96 60

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marmara University
Registry
ClinicalTrials.gov
Start date
2 June 2026
Est. completion
2 May 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Numeric Rating Scale (NRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov